Legend Biotech (LEGN) Tops Q3 EPS by 14c

Legend Biotech (NASDAQ: LEGN) reported Q3 EPS of ($0.17), $0.14 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $96.01 million versus the consensus estimate of $97.42 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• UBS Reiterates Buy Rating on Dollar Tree (DLTR)
• Delta Air Lines stock climbs on earnings beat and strong guidance